Feeling stuck in the repetitive routine of caregiving
When I wake up in the morning, I do the same things in the same order: Examine the pillbox. Send a text to my mum…
Myeloma
IGI, Abbvie team up to advance myeloma treatment ISB 2001
Ichnos Glenmark Innovation (IGI) is partnering with Abbvie to advance the development of ISB 2001, a multiple myeloma treatment candidate that’s now in…
What do we do with the taboo topic of caregiver anger?
I have quite a lot of friends who are caregivers like me. Every day and night, they provide care, attention, and company to their patients,…
FDA OKs label changes to boost CAR T-cell therapy use for cancer
The U.S. Food and Drug Administration (FDA) has approved label updates for two Bristol Myers Squibb (BMS) CAR T-cell therapies, both for the treatment…
The art of distraction: Why sometimes we avoid ‘cancer talk’
There is an unspoken rule that seems to apply to all cancer caregivers. It goes something like this: You should always be serious, present, and…
Lynozyfic wins FDA accelerated approval for treating RRMM adults
Linvoseltamab, now branded as Lynozyfic, has received accelerated approval from the U.S. Food and Drug Administration (FDA) for treating adults with relapsed or refractory…
Recognizing the invisible labor we perform as caregivers
I have 27 browser tabs open on my laptop and 33 on my phone. They range from grocery lists with foods low in sodium to…
EU panel backs 1st-line Sarclisa for transplant-eligible myeloma
A European Medicines Agency committee has recommended that Sarclisa (isatuximab), used in combination with standard-of-care medications, be approved for the treatment of adults newly…
As a caregiver, I’m always on the lookout for myeloma research news
The word “caregiver” usually conjures up images of hands-on support: providing comfort, helping out with everyday tasks, and managing medications. However, for those of us…
EU panel backs Darzalex for high-risk smoldering multiple myeloma
A European Medicines Agency (EMA) committee recommended that Darzalex (daratumumab) given as an under-the-skin injection be approved for people with smoldering multiple myeloma (SMM)…
